跳至主要内容
临床试验/NCT03566563
NCT03566563已完成不适用

Epidemiology of Chronic Hepatitis C and Modelling for Disease Burden Study

Changi General Hospital1 个研究点 分布在 1 个国家目标入组 520 人开始时间: 2017年2月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
520
试验地点
1
主要终点
HCV Sero-prevalence at Halfway Houses

研究概览

简要总结

Hepatitis C (HCV) is a major health problem amongst people who inject drugs (PWID) and have limited contact with health care services. Halfway houses (HH) serve to reintegrate former drug users into society. Strategies to eliminate HCV must focus on screening for HCV amongst HH. Linkage to care for PWID population is an issue globally.

The aim is to determine the sero-prevalence, demographics, disease distribution and factors associated with the risk of HCV transmission amongst former drug users at Halfway Houses. The secondary aim would be to determine the best models of care that can be used to link these individuals to existing healthcare services in a pragmatic, randomised fashion

Halfway Houses are invited to participate in a program of HCV education, point-of-care screening using Oraquick test and staging with Fibroscan® by a small mobile team of healthcare workers. A detailed survey regarding illicit drug injecting practices is performed. Those who are tested positive are referred to medical care.

It is anticipated that the prevalence of Hepatitis C within the drug injecting population along with the stages of liver disease such that models for disease burden can be determined.

详细描述

This is a pragmatic observational study of point of care HCV screening in the halfway house resident /PWID population.

In the secondary aim the HCV positive subjects are randomised to traditional referral pathway (HCV positive cases attend primary care facilities to get referral to specialist clinic in hospital) and 'direct' open access where the HCV positive cases has direct open access to specialist clinic as above (by passing primary care physicians). We observe the no. of subjects being linkage to specialist care, and HCV treatment

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Former Drug Users residing in Halfway Houses

排除标准

  • Age below 21 years
  • Residents of Halfway Houses who have never used drugs

结局指标

主要结局

HCV Sero-prevalence at Halfway Houses

时间窗: 24 months

The number of HCV Sero positive cases at Halfway Houses will be measured

次要结局

  • Linkage to Care(24 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Epidemiology of Chronic Hepatitis C and Disease... | 临床试验